Company Badge
USPTO Data Jan 1 1976 - Nov 3 2026
8 Patents
#70 in Bellevue, WA
#827 in Washington
#35,984 in US
Angiotech Pharmaceuticals (US), Inc.
Forward Citations = 144
15 inventors:
Bellevue, WA, United States of America
Angiotech Pharmaceuticals (US), Inc.
Calculating rank
% Expired Patents = 100.0
Trademarks = 1
Forward Citations = 144
Loading Chart...
Loading Chart...
15 inventors (with patents filed for the assignee):
George Y Daniloff (3 out of 18 patents)
Olof Mikael Trollsas (3 out of 24 patents)
Frank A DeLustro (3 out of 43 patents)
4. Michael Ngo (2 out of 8 patents)
5. Woonza M Rhee (2 out of 54 patents)
6. Samuel T Crews (2 out of 34 patents)
7. Philip Michael Toleikis (2 out of 17 patents)
8. David M Gravett (2 out of 26 patents)
9. Richard A Berg (2 out of 56 patents)
10. Louis C Sehl (1 out of 15 patents)
11. Donald G Wallace (1 out of 40 patents)
12. David Toman (1 out of 4 patents)
13. George H Chu (1 out of 43 patents)
14. John R Daniels (1 out of 16 patents)
15. Jacqueline Anne Schroeder (1 out of 21 patents)
8 patents:
Company Overview
Angiotech Pharmaceuticals (US), Inc. is a biotechnology company focused on developing and commercializing innovative medical devices and pharmaceutical products. The company's products are designed to improve patient outcomes in the fields of surgery, wound management, and drug delivery. With a commitment to research and development, Angiotech Pharmaceuticals (US), Inc. aims to create cutting-edge solutions that meet the needs of healthcare providers and patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Angiotech Pharmaceuticals (US), Inc.. Retrieved from https://idiyas.com/company/angiotech-pharmaceuticals-us
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]